Our data show marked CD4+ T lymphocytes alterations in DMARD-naïve RA patients and two different populations can be identified by the pattern of activation/differentiation CD4+ T subset redistribution and CD28 expression. This evidence concerns the gene CD4 and rheumatoid arthritis.